Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer: Updated survivl in the TAX 327 study

DR Berthold, GR Pond, F Soban, Pirkko-Liisa Kellokumpu-Lehtinen, R de WIT, M Eisenberger, IF Tannock

Research output: Contribution to journal › Article › Scientific › peer-review

1000 Citations (Scopus)

Original language	English
Pages (from-to)	242-245
Journal	JOURNAL OF CLINICAL ONCOLOGY
Volume	26
Issue number	2
DOIs	https://doi.org/10.1200/jco.2007.12.4008
Publication status	Published - 2008
Publication type	A1 Journal article-refereed

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{4197ec005da84d219bd24dc71c8148f8,

title = "Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer: Updated survivl in the TAX 327 study",

author = "DR Berthold and GR Pond and F Soban and Pirkko-Liisa Kellokumpu-Lehtinen and {de WIT}, R and M Eisenberger and IF Tannock",

year = "2008",

doi = "10.1200/jco.2007.12.4008",

language = "English",

volume = "26",

pages = "242--245",

journal = "JOURNAL OF CLINICAL ONCOLOGY",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "2",

}

TY - JOUR

T1 - Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer: Updated survivl in the TAX 327 study

AU - Berthold, DR

AU - Pond, GR

AU - Soban, F

AU - Kellokumpu-Lehtinen, Pirkko-Liisa

AU - de WIT, R

AU - Eisenberger, M

AU - Tannock, IF

PY - 2008

Y1 - 2008

U2 - 10.1200/jco.2007.12.4008

DO - 10.1200/jco.2007.12.4008

M3 - Article

SN - 0732-183X

VL - 26

SP - 242

EP - 245

JO - JOURNAL OF CLINICAL ONCOLOGY

JF - JOURNAL OF CLINICAL ONCOLOGY

IS - 2

ER -